Obesity, Morbid Clinical Trials

64 recruiting

Obesity, Morbid Trials at a Glance

64 actively recruiting trials for obesity, morbid are listed on ClinicalTrialsFinder across 6 cities in 22 countries. The largest study group is Not Applicable with 25 trials, with the heaviest enrollment activity in Trondheim, Chicago, and Québec. Lead sponsors running obesity, morbid studies include Norwegian University of Science and Technology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, and Christopher C. Thompson, MD, MSc.

Browse obesity, morbid trials by phase

Treatments under study

About Obesity, Morbid Clinical Trials

Looking for clinical trials for Obesity, Morbid? There are currently 64 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Obesity, Morbid trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Obesity, Morbid clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 64 trials

Recruiting
Not Applicable

DIStal gastriC Bypass OUtcome in Revision SurgEry After Roux-en-y Gastric Bypass

Weight GainObesity, Morbid
St. Antonius Hospital150 enrolled8 locationsNCT04894838
Recruiting
Phase 4

Evaluation of Propofol Dosing Based on Total Body Weight Using Closes-loop Anaesthesia Delivery System

AnesthesiaObesity, MorbidPropofol
Sir Ganga Ram Hospital46 enrolled1 locationNCT05305313
Recruiting
Not Applicable

Transpulmonary Pressure - Guided Mechanical Ventilation in Morbidly Obese ARDS Patients: a Feasibility Study.

ARDS, HumanObesity, Morbid
Assistance Publique - Hôpitaux de Paris40 enrolled5 locationsNCT06119516
Recruiting
Not Applicable

Long-term, Substantial Weight Loss and Insulin Regulation of Lipolysis

Obesity, Morbid
Mayo Clinic30 enrolled1 locationNCT03868592
Recruiting

Efficacy and Safety of Endoscopic Antral Myotomy as a Novel Weight Loss Procedure

ObesityMetabolic DiseaseDelayed Gastric Emptying Following Procedure+2 more
Christopher C. Thompson, MD, MSc30 enrolled1 locationNCT05711758
Recruiting
Not Applicable

Trans-nasal Endoscopy for Bariatric Patients

ObesityGastrointestinal DiseasesObese+2 more
Christopher C. Thompson, MD, MSc100 enrolled1 locationNCT06200961
Recruiting

Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity

Obesity, MorbidNASH - Nonalcoholic SteatohepatitisChronic Inflammation
Mayo Clinic60 enrolled1 locationNCT04232566
Recruiting
Not Applicable

Time-restricted Eating Among Pregnant Females With Severe Obesity

Time Restricted EatingObesity, Morbid
University of Illinois at Chicago60 enrolled1 locationNCT06477120
Recruiting
Not Applicable

Management of Sleeve Gastrectomy Failure Using Single-anastomosis Metabolic Surgery

ObesityObesity, Morbid
Laval University151 enrolled1 locationNCT05242835
Recruiting
Not Applicable

Postextubation Use of Noninvasive Respiratory Support in Severely Obese Patients

Obesity, Morbid
Rush University Medical Center250 enrolled5 locationsNCT05918575
Recruiting
Not Applicable

Bariatric Surgery and Modulation of Perceived Satiety

Obesity, Morbid
Istituto Auxologico Italiano60 enrolled1 locationNCT05777928
Recruiting
Early Phase 1

Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues

ObesityMultiple SclerosisLong COVID+4 more
University of Chicago30 enrolled1 locationNCT06171152
Recruiting
Not Applicable

Low Impact Laparoscopy In Bariatric Surgery

Obesity, Morbid
Fondazione Policlinico Universitario Campus Bio-Medico128 enrolled1 locationNCT07119437
Recruiting
Phase 4

Improving Efficacity of Sleeve Gastrectomy With Naltrexone/Bupropion Extended-release Tablet

Obesity, MorbidObesity; Drug
Laval University108 enrolled1 locationNCT06620562
Recruiting
Phase 4

Role of Tranexamic Acid in Reducing Hemorrhagic Events in Bariatric Surgery

Bariatric SurgeryObesity, MorbidHemorrhage
Patel Hospital, Pakistan140 enrolled1 locationNCT07098780
Recruiting

Bone Health After Bariatric Surgery in Patients With Type 2 Diabetes

Bariatric SurgeryDiabetes Mellitus, Type 2Obesity, Morbid+1 more
CHU de Quebec-Universite Laval100 enrolled3 locationsNCT03455868
Recruiting

Bariatric Surgery and Pharmacokinetics of Losartan

Obesity, Morbid
Norwegian University of Science and Technology12 enrolled1 locationNCT03519893
Recruiting

Bariatric Surgery and Pharmacokinetics of Lamotrigine

Obesity, Morbid
Norwegian University of Science and Technology12 enrolled1 locationNCT03497143
Recruiting

Bariatric Surgery and Pharmacokinetics of Venlafaxine

Obesity, Morbid
Norwegian University of Science and Technology12 enrolled1 locationNCT03532477
Recruiting

Bariatric Surgery and Pharmacokinetics of Quetiapine

Obesity, Morbid
Norwegian University of Science and Technology12 enrolled1 locationNCT03449472